Calumet Q2 revenue beats expectations, net loss widens

Reuters
Aug 08
Calumet <a href="https://laohu8.com/S/QTWO">Q2</a> revenue beats expectations, net loss widens

Overview

  • Calumet Q2 revenue beats analyst expectations, driven by strong Specialties performance

  • Net loss widens to $147.9 mln from $39.1 mln in prior year

  • Adjusted EBITDA with Tax Attributes rises to $76.5 mln, aided by cost savings

Outlook

  • Calumet expects Montana Renewables SAF production of 120-150 mln gallons by Q2 2026

Result Drivers

  • COST REDUCTIONS - Achieved $42 mln in year-over-year operating cost savings through first half of 2025

  • SPECIALTIES PERFORMANCE - Strong sales and margin expansion despite planned turnaround at Shreveport facility

  • MONTANA RENEWABLES - Record operational performance and reduced operating costs, enhancing competitive position

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$1.03 bln

$925.20 mln (5 Analysts)

Q2 EPS

-$1.7

Q2 Net Income

-$147.90 mln

Q2 Adjusted EBITDA

$55.10 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the oil & gas refining and marketing peer group is "buy"

  • Wall Street's median 12-month price target for Calumet Inc is $17.00, about 12.3% above its August 7 closing price of $14.91

Press Release: ID:nPn2sNgSza

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10